Norcal Medical Research, Inc.

10/28/2025

Our FALL newsletter highlights exciting clinical trials for weight loss and hypothyroidism. We're currently recruiting participants for a study on eloralintide, a promising new weight loss drug for persons with type 2 diabetes, and exploring alternative thyroid treatments. Call us at 415.461.1585 to learn more about our studies and how you can participate.

https://conta.cc/46RF3Qv

10/11/2025

New weight loss study for people with Type 2 Diabetes! Call 415-461-1585 for details!

08/18/2025

NorCal is conducting a clinical trial to compare Armour desiccated animal thyroid with synthetic levothyroxine for treatment of hypothyroidism. If you have hypothyroidism and are on a stable daily dose of levothyroxine, you may qualify to participate. To learn more about our study check out our August newsletter.

Contact us at 415-461-1585 or info@norcalmedicalresearch.com.



https://conta.cc/4n9hJTR

Email from Linda M. Gaudiani MD   Possibilities today...Treatments Tomorrow AUGUST 2025   If you know someone who might benefit from this newsletter, please forward it to them! Greetings friends of N

06/10/2025

We just published our summer newsletter! Find out about our new weight loss study for persons with type 2 diabetes: it is testing a new ORAL GLP-1 medication to help with weight loss and HA1C lowering. Our medical director also discusses one of her favorite topics: the importance of nutritional and lifestyle counseling when losing weight. https://conta.cc/447i6r0

06/04/2025

We are now doing a clinical trial of a NEW ORAL WEIGHT LOSS MEDICATION to study its effects on lowering HA1C in overweight persons with type 2 diabetes. If your HA1C is over 7% call us to see if you qualify!

05/03/2025

Great news! We are extending enrollment for our weight loss study targeting individuals with type 2 diabetes and A1C >7%. This study evaluates the effectiveness of tirzepatide combined with long-acting receptor amylin. Join us in advancing healthcare through clinical research.

https://conta.cc/3RJOTf5

05/01/2025

We are currently enrolling patients in clinical studies for weight loss and A1C lowering for persons with Type 2 Diabetes. Call us to see if you might qualify!

Linda Gaudiani, MD FACE FACP - Medical Director
Elizabeth Lowe,MD
Irene Teper, MD

03/28/2025

Our March/April Newsletter is out! Find out about our currently enrolling diabetes/obesity and thyroid studies, and the latest news about GLP-1s, including the shift in how obesity is now treated and perceived, the incredible efficacy of GLP1 medications like Tirzepatide and recent developments in the availabilty of compounded GLP1s.

Contact us with any questions at 415.461.1585 or info@norcalmedicalresearch.com

Email from NORCAL Medical Research Linda M. Gaudiani MD   Possibilities today...Treatments Tomorrow MARCH/APRIL 2025   If you know someone who might benefit from this newsletter, please forward it to

03/25/2025

We do clinical trials for weight loss and A1C lowering! We are located north of San Francisco, just across the Golden Gate Bridge.

03/08/2025

IS YOUR A1C OVER 7%?

NorCal Medical Research is conducting studies in the San Francisco North Bay of investigational weight loss medications that may help overweight people with type 2 diabetes to reach treatment goals!!

You may qualify if you:
• Have an A1C over 7%
• Have type 2 diabetes for at least 6 months on diet and/or oral medication only
• Are not currently on weight loss medication
• Are aged 18 to 75
• Have not taken part in a clinical research study for obesity or overweight in the past year

If you qualify, you’ll receive study medication per protocol, lifestyle and dietary counseling, periodic laboratory testing, EKG and clinical follow-up at no cost. A stipend is provided for your time and travel.

For further information, please call NorCal Medical Research 415-461-1585 or visit us at NorCalMedicalResearch.com.

02/22/2025

Just published on Wednesday, February 19 in the Marin Independent Journal, the latest article by Dr. Linda Gaudiani (NorCal's Medical Director) on GLP-1s, how they are revolutionizing weight management and diabetes care, and the importance of clinical trials.

When I tell people I direct clinical research studies, I often encounter surprise. “Aren’t you a physician?” they ask. It seems many don’t fully grasp the crucial role of cl…